Thank You Dr. Rufino Monteiro, for sending me an attachment on Pioglitazone drug effect on diabetic patients.
Let me give you my comments as a lay person which you may consider it as important in the point of view on prescribing this drug: After reading the effect of this drug Pioglitazone, I come to understand that this drug serves the best purpose and act on insulin resistance. Also it has the benefits on reducing cholesterol and acts as an inflammatory marker . Third it allows internal insulin to work in the body and fourth is a low cost drug. It has also been prescribed as a 2nd and 3rd line of treatment. With all the above advantages I still find no answers why this drug was officially banned. It has been reported that this drug causes urinary bladder cancer and heart failure. Now is that the doctors still think that this drug can be prescribed in India, after knowing from certain developed countries except France who have already decided to ban. That means this drug is still under dispute. In order not to take any risk it will be advisable not to continue prescribing this drug as the doctors may find one day that the chances of cancer and heart failure are high and at that point of time and it will be too late. Now, coming to the advantage that the drug works for reducing Cholesterol levels, doctors always have other much better substitutes for reducing the cholesterol and not to depend on the advantage of this drug. Regarding insulin resistance advantages, there might be better drug coming in future once this drug is banned in toto, and probably who knows that somebody may do a Research for a better drug for the insulin resistance. It is better not to take any risk on this drug which is under dispute. The report says that the physician should wisely prescribe this drug after know the patient history and health on diabetics. There can be certain errors in less experience physicians who may not study well to regulate this drug and definitely chances will be higher to get into cancer or heart failure if they prescribe this drug on routine basis. There are always other alternatives to lower the Type-II diabetis with some other drug or insulin or combination with both, and avoid the risks of effect of the drug Piogitazone . It is well know abroad and in India that the research is on war footing for the the cure of diabetis and who knows one day we may know very soon there may be a much better drug than Piogitazone in the market. Prevention is better than cure. Stephen Dias D.Paula On 5 July 2013 17:48, rufino . <ruf...@sify.com> wrote: > STEPHEN , > > PLEASE READ . >